These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18228182)

  • 1. Progress on baculovirus-derived influenza vaccines.
    Cox MM
    Curr Opin Mol Ther; 2008 Feb; 10(1):56-61. PubMed ID: 18228182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel recombinant influenza vaccine in insect cells.
    McPherson CE
    Biologicals; 2008 Nov; 36(6):350-3. PubMed ID: 18804387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-based protein vaccines for influenza.
    Cox MM
    Curr Opin Mol Ther; 2005 Feb; 7(1):24-9. PubMed ID: 15732526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fast track influenza virus vaccine produced in insect cells.
    Cox MM; Hashimoto Y
    J Invertebr Pathol; 2011 Jul; 107 Suppl():S31-41. PubMed ID: 21784229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
    Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
    Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.
    Haynes JR; Dokken L; Wiley JA; Cawthon AG; Bigger J; Harmsen AG; Richardson C
    Vaccine; 2009 Jan; 27(4):530-41. PubMed ID: 19026705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
    Latham T; Galarza JM
    J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza virus-like particle vaccines.
    Haynes JR
    Expert Rev Vaccines; 2009 Apr; 8(4):435-45. PubMed ID: 19348559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use.
    Safdar A; Cox MM
    Expert Opin Investig Drugs; 2007 Jul; 16(7):927-34. PubMed ID: 17594180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.
    D'Aoust MA; Lavoie PO; Couture MM; Trépanier S; Guay JM; Dargis M; Mongrand S; Landry N; Ward BJ; Vézina LP
    Plant Biotechnol J; 2008 Dec; 6(9):930-40. PubMed ID: 19076615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FluBlok, a recombinant influenza vaccine.
    Huber VC; McCullers JA
    Curr Opin Mol Ther; 2008 Feb; 10(1):75-85. PubMed ID: 18228185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M2e-based universal influenza A vaccine.
    Fiers W; De Filette M; El Bakkouri K; Schepens B; Roose K; Schotsaert M; Birkett A; Saelens X
    Vaccine; 2009 Oct; 27(45):6280-3. PubMed ID: 19840661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines).
    Doroshenko A; Halperin SA
    Expert Rev Vaccines; 2009 Jun; 8(6):679-88. PubMed ID: 19485748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FluBlok, a next generation influenza vaccine manufactured in insect cells.
    Cox MM; Hollister JR
    Biologicals; 2009 Jun; 37(3):182-9. PubMed ID: 19297194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the Yield and Quality of Influenza Virus-like Particles (VLPs) Produced in Insect Cells by Inhibiting Cytopathic Effects of Matrix Protein M2.
    Zak AJ; Hill BD; Rizvi SM; Smith MR; Yang M; Wen F
    ACS Synth Biol; 2019 Oct; 8(10):2303-2314. PubMed ID: 31487465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. World Influenza Congress Europe 2009.
    Silman NJ
    Expert Rev Vaccines; 2010 Mar; 9(3):273-5. PubMed ID: 20218855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative influenza vaccines made by insect cells.
    Krammer F; Grabherr R
    Trends Mol Med; 2010 Jul; 16(7):313-20. PubMed ID: 20570562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a vaccine against pandemic influenza viruses: current status and perspectives.
    Ilyinskii PO; Thoidis G; Shneider AM
    Int Rev Immunol; 2008; 27(6):392-426. PubMed ID: 19065349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
    King JC; Cox MM; Reisinger K; Hedrick J; Graham I; Patriarca P
    Vaccine; 2009 Nov; 27(47):6589-94. PubMed ID: 19716456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.